ClinicalTrials.gg
CompletedNCT04929184Updated Jul 16, 2026Results posted

Speech Processing in Stuttering

An interventional study of Speech and non-speech tasks in Stuttering, Stuttering, Childhood and Stuttering, Adult, sponsored by University of Michigan. Completed at 2 sites in United States. Open to participants aged 6 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by University of Michigan · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
145
Allocation
Non-randomized
Ages
6 Years to 65 Years
Sex
All
01

Study summary

This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

Read the detailed description

The study team will update the record to include the secondary identification number once the NIH has released the funds.

02

Conditions studied

  • Stuttering
  • Stuttering, Childhood
  • Stuttering, Adult

Browse trials for

Keywords

  • Healthy children
  • Healthy Adults
03

In context

Stuttering

74 studies on the registry are indexed under Stuttering; 23 are open to participants now.

This study's enrollment of 145 is above the median of 44 across 57 interventional studies indexed under Stuttering.

Browse Stuttering studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.

Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (adults who do not stutter):

  • 18-65 years old
  • English as primary language
  • Normal speech, language, hearing, cognition

Exclusion criteria: (adults who do not stutter)

  • Personal or family history of stuttering
  • Major medical or psychiatric illness

Inclusion criteria: (adults who stutter)

  • Aged 18-65 years
  • English as primary language
  • Normal speech, language, hearing, cognition (other than stuttering)
  • Currently stutters

Exclusion criteria: (adults who stutter)

  • Speech therapy within the past year
  • Major medical or psychiatric illness

Inclusion criteria: (children who do not stutter)

  • Aged 6 to 17 years
  • English as primary language
  • Normal speech, language, hearing, cognition

Exclusion criteria: (children who do not stutter)

  • Personal or family history of stuttering
  • Major medical or psychiatric illness
  • Language/motor delay

Inclusion criteria: (children who stutter)

  • Aged 6 to 17 years
  • English as primary language
  • Normal speech, language, hearing, cognition (other than stuttering)
  • Currently stutters

Exclusion criteria: (children who stutter)

  • Major medical or psychiatric illness
  • Language/motor delay
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
145 participants (actual)

Study arms

  • Experimental
    Adults who stutter (AWS)

    Participants will have 2 visits.

    Behavioral: Speech and non-speech tasks

  • Other
    Healthy Adults

    Participants will have 2 visits.

    Behavioral: Speech and non-speech tasks

  • Experimental
    Children who Stutter

    Participants will have 1 visit.

    Behavioral: Speech and non-speech tasks

  • Other
    Healthy Children

    Participants will have 1 visit.

    Behavioral: Speech and non-speech tasks

Interventions

  • BehavioralSpeech and non-speech tasks

    Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.

06

What researchers measure

Primary outcomes

  1. Phase Locking Value (PLV) - Session 1 Speech Tasks

    Participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults were not instructed to attempt to match the cadence (Implicit task). Child participants were instructed to attempt to match the cadence (Explicit task).

    Time frame: Session 1 (up to 4 hours)

  2. Phase Locking Value (PLV) - Session 2 Speech Tasks

    Adult participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. Child participants did not attend Session 2. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults completed this task twice. For the first test, they were not instructed to attempt to match the cadence (Implicit task). For the second test, they were instructed to attempt to match the cadence (Explicit task).

    Time frame: Session 2 (up to 4 hours)

Secondary outcomes

  1. R Statistic (Resultant Vector Length)

    In tapping synchronization (sensorimotor synchronization) research, the R statistic generally refers to the resultant vector length derived from circular statistics, used to quantify the consistency and stability of a participant's tapping relative to a rhythmic stimulus. It ranges from 0 to 1. 0=Complete inconsistency (taps are uniformly distributed). 1=Perfect consistency (all taps occur at the exact same relative phase).

    Time frame: Session 1 (up to 4 hours)

07

Results

Posted Jul 16, 2026

Participant flow

Visit 1
Participant flow — Visit 1
MilestoneAdults Who Stutter (AWS)Healthy AdultsChildren Who Stutter (CWS)Healthy Children
Started55671310
Completed45531310
Not completed101400
Withdrew: Lost to follow-up5800
Withdrew: Determined to be ineligible5600
Visit 2 (Adults only)
Participant flow — Visit 2 (Adults only)
MilestoneAdults Who Stutter (AWS)Healthy AdultsChildren Who Stutter (CWS)Healthy Children
Started455300
Completed435300
Not completed2000
Withdrew: Lost to follow-up2000

Outcome measures

PrimaryPhase Locking Value (PLV) - Session 1 Speech Tasks

Participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults were not instructed to attempt to match the cadence (Implicit task). Child participants were instructed to attempt to match the cadence (Explicit task).

Time frame:
Session 1 (up to 4 hours)
Reported as:
Mean · PLV
Phase Locking Value (PLV) - Session 1 Speech Tasks
PLVAdults Who Stutter (AWS)Healthy AdultsChildren Who Stutter (CWS)Healthy Children
Implicit0.42 ± 0.150.42 ± 0.14——
Explicit——0.42 ± 0.150.44 ± 0.21
PrimaryPhase Locking Value (PLV) - Session 2 Speech Tasks

Adult participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. Child participants did not attend Session 2. The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults completed this task twice. For the first test, they were not instructed to attempt to match the cadence (Implicit task). For the second test, they were instructed to attempt to match the cadence (Explicit task).

Time frame:
Session 2 (up to 4 hours)
Reported as:
Mean · PLV
Phase Locking Value (PLV) - Session 2 Speech Tasks
PLVAdults Who Stutter (AWS)Healthy AdultsChildren Who Stutter (CWS)Healthy Children
Implicit0.43 ± 0.150.42 ± 0.16——
Explicit0.56 ± 0.220.57 ± 0.24——
SecondaryR Statistic (Resultant Vector Length)

In tapping synchronization (sensorimotor synchronization) research, the R statistic generally refers to the resultant vector length derived from circular statistics, used to quantify the consistency and stability of a participant's tapping relative to a rhythmic stimulus. It ranges from 0 to 1. 0=Complete inconsistency (taps are uniformly distributed). 1=Perfect consistency (all taps occur at the exact same relative phase).

Time frame:
Session 1 (up to 4 hours)
Reported as:
Mean · R
R Statistic (Resultant Vector Length)
RAdults Who Stutter (AWS)Healthy AdultsChildren Who Stutter (CWS)Healthy Children
R Statistic (Resultant Vector Length)0.91 ± 0.10.91 ± .08.08 ± .02.07 ± .004

Adverse events

Collected over From enrollment to study completion, up to two weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Adults Who Stutter (AWS)0/55 (0%)0/55 (0%)0/55 (0%)
Healthy Adults0/67 (0%)0/67 (0%)0/67 (0%)
Children Who Stutter (CWS)0/13 (0%)0/13 (0%)0/13 (0%)
Healthy Children0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Adults Who Stutter (AWS)Healthy AdultsChildren Who StutterHealthy ChildrenTotal
Mean32.1 ± 11.230.7 ± 10.39.2 ± 1.210.9 ± 1.720.7 ± 6.1
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Adults Who Stutter (AWS)Healthy AdultsChildren Who StutterHealthy ChildrenTotal
Male39409795
Female16274350
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Adults Who Stutter (AWS)Healthy AdultsChildren Who StutterHealthy ChildrenTotal
American Indian or Alaska Native01001
Asian1390022
Native Hawaiian or Other Pacific Islander00000
Black or African American672015
White324891099
More than one race42208
Unknown or Not Reported00000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Adults Who Stutter (AWS)Healthy AdultsChildren Who StutterHealthy ChildrenTotal
Hispanic or Latino270211
Not Hispanic or Latino5360138134
Unknown or Not Reported00000
Region of Enrollment
Region of Enrollment(participants)Adults Who Stutter (AWS)Healthy AdultsChildren Who StutterHealthy ChildrenTotal
United States55671310145
08

Study locations

2 sites
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
  • Michigan State University
    East Lansing, Michigan 48824, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04929184
Responsible party
Emily O'Dell Garnett (Research Assistant Professor, University of Michigan) — Principal investigator
First posted
Jun 18, 2021
Start date
Apr 4, 2022
Primary completion
Jun 16, 2025
Completion
Jun 16, 2025
Results posted
Jul 16, 2026
Last update
Jul 16, 2026

Study contacts

Emily Garnett, PhD
principal investigator · University of Michigan

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion